Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 15 (RPL32P15) is a processed pseudogene corresponding to the ribosomal protein L32 gene family. Unlike its parental gene, RPL32, which encodes a structural protein of the 60S ribosomal subunit, RPL32P15 is believed to be non-functional and does not produce a protein product. Processed pseudogenes are non-coding genomic DNA sequences derived from reverse-transcribed mRNA reintegrated into the genome; they generally lack introns and possess sequence similarity with their functional ancestors but are not transcribed or translated into a protein. There are no reports of this pseudogene serving as a receptor, enzyme, transporter, transcription factor, or any other classical druggable target, nor is there evidence of involvement in signaling, disease processes, or drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 15 (RPL32P15).